|
US9528160B2
(en)
|
2008-11-07 |
2016-12-27 |
Adaptive Biotechnolgies Corp. |
Rare clonotypes and uses thereof
|
|
US9506119B2
(en)
|
2008-11-07 |
2016-11-29 |
Adaptive Biotechnologies Corp. |
Method of sequence determination using sequence tags
|
|
EP2364368B1
(en)
|
2008-11-07 |
2014-01-15 |
Sequenta, Inc. |
Methods of monitoring conditions by sequence analysis
|
|
US8628927B2
(en)
|
2008-11-07 |
2014-01-14 |
Sequenta, Inc. |
Monitoring health and disease status using clonotype profiles
|
|
US8748103B2
(en)
|
2008-11-07 |
2014-06-10 |
Sequenta, Inc. |
Monitoring health and disease status using clonotype profiles
|
|
US9365901B2
(en)
|
2008-11-07 |
2016-06-14 |
Adaptive Biotechnologies Corp. |
Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
|
|
DK3059337T3
(da)
|
2009-01-15 |
2019-07-22 |
Adaptive Biotechnologies Corp |
Adaptive immunity profiling og metoder til frembringelse af monoklonale antibodier
|
|
RU2014144463A
(ru)
|
2009-06-25 |
2015-06-20 |
Фред Хатчинсон Кансэр Рисёч Сентер |
Способ измерения адаптивного иммунитета
|
|
US8835358B2
(en)
|
2009-12-15 |
2014-09-16 |
Cellular Research, Inc. |
Digital counting of individual molecules by stochastic attachment of diverse labels
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
ES3005233T3
(en)
|
2010-10-01 |
2025-03-14 |
Modernatx Inc |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
PL3892295T3
(pl)
|
2011-05-24 |
2023-07-24 |
BioNTech SE |
Zindywidualizowane szczepionki przeciwnowotworowe
|
|
US10385475B2
(en)
|
2011-09-12 |
2019-08-20 |
Adaptive Biotechnologies Corp. |
Random array sequencing of low-complexity libraries
|
|
US9279159B2
(en)
|
2011-10-21 |
2016-03-08 |
Adaptive Biotechnologies Corporation |
Quantification of adaptive immune cell genomes in a complex mixture of cells
|
|
EP3388535B1
(en)
|
2011-12-09 |
2021-03-24 |
Adaptive Biotechnologies Corporation |
Diagnosis of lymphoid malignancies and minimal residual disease detection
|
|
US9499865B2
(en)
|
2011-12-13 |
2016-11-22 |
Adaptive Biotechnologies Corp. |
Detection and measurement of tissue-infiltrating lymphocytes
|
|
JP2015501844A
(ja)
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
|
CA2865575C
(en)
|
2012-02-27 |
2024-01-16 |
Cellular Research, Inc. |
Compositions and kits for molecular counting
|
|
DK2823060T3
(en)
|
2012-03-05 |
2018-05-28 |
Adaptive Biotechnologies Corp |
Determination of associated immune receptor chains from frequency-matched subunits
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
WO2013151663A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of membrane proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
EP3091089B1
(en)
|
2012-05-08 |
2019-01-23 |
Adaptive Biotechnologies Corporation |
Method for measuring and calibrating amplification bias in multiplexed pcr reactions
|
|
ES2729759T3
(es)
*
|
2012-07-12 |
2019-11-06 |
Persimmune Inc |
Vacunas contra el cáncer personalizadas y terapias celulares inmunitarias adoptivas
|
|
WO2014028429A2
(en)
|
2012-08-14 |
2014-02-20 |
Moderna Therapeutics, Inc. |
Enzymes and polymerases for the synthesis of rna
|
|
AU2013323368B2
(en)
|
2012-09-28 |
2019-03-21 |
The University Of Connecticut |
Identification of tumor-protective epitopes for the treatment of cancers
|
|
US20160002731A1
(en)
|
2012-10-01 |
2016-01-07 |
Adaptive Biotechnologies Corporation |
Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
|
|
US10150996B2
(en)
|
2012-10-19 |
2018-12-11 |
Adaptive Biotechnologies Corp. |
Quantification of adaptive immune cell genomes in a complex mixture of cells
|
|
ES2921623T3
(es)
|
2012-11-26 |
2022-08-30 |
Modernatx Inc |
ARN modificado terminalmente
|
|
EP2925348B1
(en)
*
|
2012-11-28 |
2019-03-06 |
BioNTech RNA Pharmaceuticals GmbH |
Individualized vaccines for cancer
|
|
WO2014093186A1
(en)
*
|
2012-12-12 |
2014-06-19 |
Garvin Alex M |
Non-invasive detection of colorectal neoplasia using circular consensus sequencing
|
|
WO2014113204A1
(en)
|
2013-01-17 |
2014-07-24 |
Personalis, Inc. |
Methods and systems for genetic analysis
|
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
US10258698B2
(en)
|
2013-03-14 |
2019-04-16 |
Modernatx, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
WO2014145992A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Adaptive Biotechnologies Corporation |
Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set
|
|
BR112015025460B1
(pt)
*
|
2013-04-07 |
2024-01-02 |
The Broad Institute, Inc. |
Método para a produção de uma vacina personalizada contra a neoplasia para um indivíduo diagnosticado como tendo uma neoplasia, vacina personalizada e uso da mesma
|
|
WO2014180490A1
(en)
*
|
2013-05-10 |
2014-11-13 |
Biontech Ag |
Predicting immunogenicity of t cell epitopes
|
|
US9708657B2
(en)
|
2013-07-01 |
2017-07-18 |
Adaptive Biotechnologies Corp. |
Method for generating clonotype profiles using sequence tags
|
|
WO2015013461A2
(en)
*
|
2013-07-26 |
2015-01-29 |
Sequenta, Inc. |
Cancer vaccination with antigen evolution
|
|
US9567645B2
(en)
|
2013-08-28 |
2017-02-14 |
Cellular Research, Inc. |
Massively parallel single cell analysis
|
|
EP3039161B1
(en)
|
2013-08-30 |
2021-10-06 |
Personalis, Inc. |
Methods and systems for genomic analysis
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
GB2535066A
(en)
|
2013-10-03 |
2016-08-10 |
Personalis Inc |
Methods for analyzing genotypes
|
|
JP2017504307A
(ja)
|
2013-10-07 |
2017-02-09 |
セルラー リサーチ， インコーポレイテッド |
アレイ上のフィーチャーをデジタルカウントするための方法およびシステム
|
|
US10801070B2
(en)
|
2013-11-25 |
2020-10-13 |
The Broad Institute, Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer
|
|
DK3077539T3
(en)
*
|
2013-12-02 |
2018-11-19 |
Personal Genome Diagnostics Inc |
Procedure for evaluating minority variations in a sample
|
|
US11725237B2
(en)
|
2013-12-05 |
2023-08-15 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
|
JP6740127B2
(ja)
*
|
2013-12-06 |
2020-08-12 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
新生物ワクチン用製剤
|
|
NZ721908A
(en)
*
|
2013-12-20 |
2022-12-23 |
Massachusetts Gen Hospital |
Combination therapy with neoantigen vaccine
|
|
WO2015134787A2
(en)
|
2014-03-05 |
2015-09-11 |
Adaptive Biotechnologies Corporation |
Methods using randomer-containing synthetic molecules
|
|
US10066265B2
(en)
|
2014-04-01 |
2018-09-04 |
Adaptive Biotechnologies Corp. |
Determining antigen-specific t-cells
|
|
DK3134131T3
(en)
|
2014-04-23 |
2022-02-07 |
Modernatx Inc |
Nucleic acid vaccines
|
|
US10017759B2
(en)
*
|
2014-06-26 |
2018-07-10 |
Illumina, Inc. |
Library preparation of tagged nucleic acid
|
|
US11338026B2
(en)
|
2014-09-10 |
2022-05-24 |
The University Of Connecticut |
Identification of immunologically protective neo-epitopes for the treatment of cancers
|
|
AU2015315005B9
(en)
|
2014-09-10 |
2021-08-12 |
Genentech, Inc. |
Immunogenic mutant peptide screening platform
|
|
US10973894B2
(en)
|
2014-10-02 |
2021-04-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human |
Methods of isolating T cells having antigenic specificity for a cancer-specific mutation
|
|
CA2966201A1
(en)
|
2014-10-29 |
2016-05-06 |
Adaptive Biotechnologies Corp. |
Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples
|
|
US10125399B2
(en)
|
2014-10-30 |
2018-11-13 |
Personalis, Inc. |
Methods for using mosaicism in nucleic acids sampled distal to their origin
|
|
US10246701B2
(en)
|
2014-11-14 |
2019-04-02 |
Adaptive Biotechnologies Corp. |
Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
|
|
EP3224384A4
(en)
|
2014-11-25 |
2018-04-18 |
Adaptive Biotechnologies Corp. |
Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
|
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
|
EP4636401A2
(en)
|
2014-12-19 |
2025-10-22 |
The Broad Institute, Inc. |
Methods for profiling the t-cell-receptor repertoire
|
|
WO2016128060A1
(en)
|
2015-02-12 |
2016-08-18 |
Biontech Ag |
Predicting t cell epitopes useful for vaccination
|
|
EP3259371B1
(en)
*
|
2015-02-19 |
2020-09-02 |
Becton, Dickinson and Company |
High-throughput single-cell analysis combining proteomic and genomic information
|
|
US11047008B2
(en)
|
2015-02-24 |
2021-06-29 |
Adaptive Biotechnologies Corporation |
Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
|
|
US10780021B2
(en)
|
2015-02-26 |
2020-09-22 |
Sio2 Medical Products, Inc. |
Cycloolefin polymer container with a scratch resistant and anti-static coating
|
|
CN107208158B
(zh)
|
2015-02-27 |
2022-01-28 |
贝克顿迪金森公司 |
空间上可寻址的分子条形编码
|
|
EP3835431B1
(en)
|
2015-03-30 |
2022-11-02 |
Becton, Dickinson and Company |
Methods for combinatorial barcoding
|
|
WO2016161273A1
(en)
|
2015-04-01 |
2016-10-06 |
Adaptive Biotechnologies Corp. |
Method of identifying human compatible t cell receptors specific for an antigenic target
|
|
US11390914B2
(en)
|
2015-04-23 |
2022-07-19 |
Becton, Dickinson And Company |
Methods and compositions for whole transcriptome amplification
|
|
ES2836273T3
(es)
*
|
2015-04-27 |
2021-06-24 |
Cancer Research Tech Ltd |
Método para el tratamiento del cáncer
|
|
WO2016180467A1
(en)
|
2015-05-11 |
2016-11-17 |
Biontech Cell & Gene Therapies Gmbh |
Enhancing the effect of car-engineered t cells by means of nucleic acid vaccination
|
|
EP3294324A1
(en)
*
|
2015-05-13 |
2018-03-21 |
Agenus Inc. |
Vaccines for treatment and prevention of cancer
|
|
CA2986235A1
(en)
|
2015-05-20 |
2016-11-24 |
The Broad Institute, Inc. |
Shared neoantigens
|
|
WO2016196229A1
(en)
|
2015-06-01 |
2016-12-08 |
Cellular Research, Inc. |
Methods for rna quantification
|
|
TWI750122B
(zh)
*
|
2015-06-09 |
2021-12-21 |
美商博德研究所有限公司 |
用於贅瘤疫苗之調配物及其製備方法
|
|
WO2017020026A1
(en)
*
|
2015-07-30 |
2017-02-02 |
Modernatx, Inc. |
Concatemeric peptide epitopes rnas
|
|
GB201516047D0
(en)
|
2015-09-10 |
2015-10-28 |
Cancer Rec Tech Ltd |
Method
|
|
JP6940484B2
(ja)
|
2015-09-11 |
2021-09-29 |
セルラー リサーチ， インコーポレイテッド |
ライブラリー正規化のための方法および組成物
|
|
EP3359670B2
(en)
|
2015-10-05 |
2024-02-14 |
ModernaTX, Inc. |
Methods for therapeutic administration of messenger ribonucleic acid drugs
|
|
WO2017059902A1
(en)
*
|
2015-10-07 |
2017-04-13 |
Biontech Rna Pharmaceuticals Gmbh |
3' utr sequences for stabilization of rna
|
|
AU2016339924B2
(en)
|
2015-10-12 |
2020-01-02 |
Nantomics, Llc |
Compositions and methods for viral cancer neoepitopes
|
|
EP3362929B1
(en)
|
2015-10-12 |
2020-08-12 |
Nantomics, LLC |
Viral neoepitopes and uses thereof
|
|
CN108430456B
(zh)
|
2015-10-22 |
2022-01-18 |
摩登纳特斯有限公司 |
癌症疫苗
|
|
KR102883915B1
(ko)
|
2015-12-16 |
2025-11-18 |
시애틀 프로젝트 코포레이션 |
신생항원 동정, 제조, 및 용도
|
|
CN105349533A
(zh)
*
|
2015-12-21 |
2016-02-24 |
生工生物工程（上海）股份有限公司 |
构建链特异性转录组文库的方法
|
|
WO2017118702A1
(en)
*
|
2016-01-08 |
2017-07-13 |
Vaccibody As |
Neoepitope rna cancer vaccine
|
|
KR102833333B1
(ko)
*
|
2016-01-08 |
2025-07-11 |
니코데 테라퓨틱스 에이에스에이 |
치료적 항암 네오에피토프 백신
|
|
JP2019513021A
(ja)
|
2016-03-24 |
2019-05-23 |
ナントセル，インコーポレイテッド |
ネオエピトープ提示のための配列の配置および配列
|
|
CR20180519A
(es)
|
2016-03-31 |
2019-03-05 |
Neon Therapeutics Inc |
Neoantígenos y métodos de su uso
|
|
AU2017254477A1
(en)
|
2016-04-18 |
2018-11-01 |
Jennifer G. ABELIN |
Improved HLA epitope prediction
|
|
EP3445392A1
(en)
*
|
2016-04-22 |
2019-02-27 |
CureVac AG |
Rna encoding a tumor antigen
|
|
EP3452614B1
(en)
|
2016-05-02 |
2023-06-28 |
Becton, Dickinson and Company |
Accurate molecular barcoding
|
|
US11260116B2
(en)
|
2016-05-04 |
2022-03-01 |
Immunovaccine Technologies Inc. |
Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof
|
|
WO2017194170A1
(en)
|
2016-05-13 |
2017-11-16 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of proteins or protein fragments for immunotherapy
|
|
US10301677B2
(en)
|
2016-05-25 |
2019-05-28 |
Cellular Research, Inc. |
Normalization of nucleic acid libraries
|
|
CN109074430B
(zh)
|
2016-05-26 |
2022-03-29 |
贝克顿迪金森公司 |
分子标记计数调整方法
|
|
US11299783B2
(en)
|
2016-05-27 |
2022-04-12 |
Personalis, Inc. |
Methods and systems for genetic analysis
|
|
JP2019517577A
(ja)
*
|
2016-05-27 |
2019-06-24 |
エトゥビクス コーポレーション |
ネオエピトープワクチン組成物及びその使用方法
|
|
US10640763B2
(en)
|
2016-05-31 |
2020-05-05 |
Cellular Research, Inc. |
Molecular indexing of internal sequences
|
|
US10202641B2
(en)
|
2016-05-31 |
2019-02-12 |
Cellular Research, Inc. |
Error correction in amplification of samples
|
|
CA3028549A1
(en)
*
|
2016-07-13 |
2018-01-18 |
Vaximm Ag |
Process for the production of a dna vaccine for cancer immunotherapy
|
|
SG11201900132QA
(en)
*
|
2016-07-20 |
2019-02-27 |
Biontech Rna Pharmaceuticals Gmbh |
Selecting neoepitopes as disease-specific targets for therapy with enhanced efficacy
|
|
US10428325B1
(en)
|
2016-09-21 |
2019-10-01 |
Adaptive Biotechnologies Corporation |
Identification of antigen-specific B cell receptors
|
|
AU2017331459B2
(en)
|
2016-09-26 |
2023-04-13 |
Becton, Dickinson And Company |
Measurement of protein expression using reagents with barcoded oligonucleotide sequences
|
|
AU2017359048B2
(en)
|
2016-11-08 |
2022-07-21 |
Becton, Dickinson And Company |
Methods for expression profile classification
|
|
KR102790039B1
(ko)
|
2016-11-08 |
2025-04-04 |
벡톤 디킨슨 앤드 컴퍼니 |
세포 표지 분류 방법
|
|
WO2018089637A1
(en)
|
2016-11-11 |
2018-05-17 |
Nantbio, Inc. |
Immunomodulatory compositions, processes for making the same, and methods for inhibiting cytokine storms
|
|
CN108090325B
(zh)
*
|
2016-11-23 |
2022-01-25 |
中国科学院昆明动物研究所 |
一种应用β-稳定性分析单细胞测序数据的方法
|
|
US20190369096A1
(en)
*
|
2017-01-13 |
2019-12-05 |
Nantbio, Inc. |
Validation of neoepitope-based treatment
|
|
ES2961580T3
(es)
|
2017-01-13 |
2024-03-12 |
Cellular Res Inc |
Revestimiento hidrófilo de canales de fluidos
|
|
CA3050109A1
(en)
*
|
2017-01-18 |
2018-07-26 |
Ichan School Of Medicine At Mount Sinai |
Neoantigens and uses thereof for treating cancer
|
|
US11549149B2
(en)
|
2017-01-24 |
2023-01-10 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
|
EP3576780A1
(en)
|
2017-02-01 |
2019-12-11 |
Modernatx, Inc. |
Immunomodulatory therapeutic mrna compositions encoding activating oncogene mutation peptides
|
|
CN110382708A
(zh)
|
2017-02-01 |
2019-10-25 |
赛卢拉研究公司 |
使用阻断性寡核苷酸进行选择性扩增
|
|
RU2768829C2
(ru)
*
|
2017-02-01 |
2022-03-24 |
МОДЕРНАТиЭкс, ИНК. |
Противораковые рнк-вакцины
|
|
CN116693695A
(zh)
|
2017-02-12 |
2023-09-05 |
百欧恩泰美国公司 |
基于hla的方法和组合物及其用途
|
|
AU2018243571B2
(en)
|
2017-03-31 |
2024-03-07 |
The Board Of Trustees Of The Leland Standford Junior University |
Methods of treating T cell exhaustion by inhibiting or modulating T cell receptor signaling
|
|
JP7457642B2
(ja)
|
2017-04-03 |
2024-03-28 |
ビオンテック ユーエス インコーポレイテッド |
タンパク質抗原およびその使用
|
|
WO2018187590A1
(en)
|
2017-04-05 |
2018-10-11 |
Modernatx, Inc. |
Reduction or elimination of immune responses to non-intravenous, e.g., subcutaneously administered therapeutic proteins
|
|
CN116983395A
(zh)
|
2017-04-24 |
2023-11-03 |
河谷细胞有限公司 |
靶向性新表位载体及其方法
|
|
TW201907937A
(zh)
|
2017-05-08 |
2019-03-01 |
美商葛利史東腫瘤科技公司 |
阿爾法病毒新抗原載體
|
|
WO2018209203A1
(en)
*
|
2017-05-11 |
2018-11-15 |
Theralase Biotech, Inc. |
Vaccine containing cancer cells inactivated by photodynamic treatment with metal-based coordination complexes, and immunotherapy method using same
|
|
EP3631471A4
(en)
|
2017-05-30 |
2021-06-30 |
Nant Holdings IP, LLC |
Circulating tumor cell enrichment using neoepitopes
|
|
WO2018226293A1
(en)
|
2017-06-05 |
2018-12-13 |
Becton, Dickinson And Company |
Sample indexing for single cells
|
|
WO2018224166A1
(en)
*
|
2017-06-09 |
2018-12-13 |
Biontech Rna Pharmaceuticals Gmbh |
Methods for predicting the usefulness of disease specific amino acid modifications for immunotherapy
|
|
JP7334124B2
(ja)
|
2017-06-21 |
2023-08-28 |
トランジェーヌ |
個別化ワクチン
|
|
CA3068437A1
(en)
|
2017-06-27 |
2019-01-03 |
The Regents Of The University Of California |
Mhc-i genotype restricts the oncogenic mutational landscape
|
|
BR112020000581A2
(pt)
*
|
2017-07-12 |
2020-07-14 |
Nouscom Ag |
polipeptídeo, ácido nucleico, vetor, coleção de um ou mais vetores de expressão, composição compreendendo uma vacina e kit de vacinação
|
|
US10636512B2
(en)
|
2017-07-14 |
2020-04-28 |
Cofactor Genomics, Inc. |
Immuno-oncology applications using next generation sequencing
|
|
US12504380B2
(en)
|
2017-09-25 |
2025-12-23 |
University Of Florida Research Foundation, Incorporated |
Immunoassays for detection of ran proteins
|
|
WO2019075112A1
(en)
|
2017-10-10 |
2019-04-18 |
Gritstone Oncology, Inc. |
IDENTIFICATION OF NEO-ANTIGENS USING HOT POINTS
|
|
KR20260008173A
(ko)
|
2017-11-22 |
2026-01-15 |
시애틀 프로젝트 코포레이션 |
신생항원에 대한 접합 에피토프 제시 감소
|
|
US20200354730A1
(en)
*
|
2017-11-27 |
2020-11-12 |
Nantcell, Inc. |
Improved Yeast Polytope Vaccine Compositions And Methods
|
|
US11254980B1
(en)
|
2017-11-29 |
2022-02-22 |
Adaptive Biotechnologies Corporation |
Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
|
|
CN109865133B
(zh)
*
|
2017-12-01 |
2021-07-09 |
上海桀蒙生物技术有限公司 |
个性化癌症疫苗的制备方法
|
|
EP3728642A4
(en)
*
|
2017-12-18 |
2021-09-15 |
Personal Genome Diagnostics Inc. |
AUTOMATIC LEARNING SYSTEM AND SOMATIC MUTATION DISCOVERY PROCESS
|
|
US11793867B2
(en)
|
2017-12-18 |
2023-10-24 |
Biontech Us Inc. |
Neoantigens and uses thereof
|
|
WO2019126209A1
(en)
|
2017-12-19 |
2019-06-27 |
Cellular Research, Inc. |
Particles associated with oligonucleotides
|
|
JP7653013B2
(ja)
|
2018-01-04 |
2025-03-28 |
アイコニック セラピューティクス リミテッド ライアビリティ カンパニー |
抗組織因子抗体、抗体薬物コンジュゲート、及び関連する方法
|
|
JP7437310B2
(ja)
*
|
2018-03-14 |
2024-02-22 |
コーニンクレッカ フィリップス エヌ ヴェ |
Ｒｎａシーケンシングデータの転写発現レベルを解釈するために局所的なユニークな特徴を使用するシステム及び方法
|
|
CA3095030A1
(en)
*
|
2018-03-30 |
2019-10-03 |
Juno Diagnostics, Inc. |
Deep learning-based methods, devices, and systems for prenatal testing
|
|
KR20210005646A
(ko)
|
2018-04-26 |
2021-01-14 |
아게누스 인코포레이티드 |
열쇼크 단백질-결합 펩티드 조성물 및 그의 이용 방법
|
|
EP3788170B1
(en)
|
2018-05-03 |
2025-01-01 |
Becton, Dickinson and Company |
Molecular barcoding on opposite transcript ends
|
|
EP3788171B1
(en)
|
2018-05-03 |
2023-04-05 |
Becton, Dickinson and Company |
High throughput multiomics sample analysis
|
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neoantigens
|
|
MX2020012649A
(es)
*
|
2018-05-25 |
2021-07-02 |
The Wistar Inst |
Neoantígenos especificos de tumor y métodos de uso de estos.
|
|
CN108897986B
(zh)
*
|
2018-05-29 |
2020-11-27 |
中南大学 |
一种基于蛋白质信息的基因组序列拼接方法
|
|
US10801064B2
(en)
|
2018-05-31 |
2020-10-13 |
Personalis, Inc. |
Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
|
|
US11814750B2
(en)
|
2018-05-31 |
2023-11-14 |
Personalis, Inc. |
Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
|
|
WO2019246286A1
(en)
|
2018-06-19 |
2019-12-26 |
Neon Therapeutics, Inc. |
Neoantigens and uses thereof
|
|
SG11202012770RA
(en)
*
|
2018-06-27 |
2021-01-28 |
Modernatx Inc |
Personalized cancer vaccine epitope selection
|
|
WO2020020444A1
(en)
*
|
2018-07-24 |
2020-01-30 |
Biontech Rna Pharmaceuticals Gmbh |
Individualized vaccines for cancer
|
|
US20220349010A1
(en)
|
2018-07-26 |
2022-11-03 |
Frame Pharmaceuticals B.V. |
Method of preparing subject-specific immunogenic compositions based on a neo open-reading-frame peptide database
|
|
IL280112B2
(en)
|
2018-07-26 |
2025-11-01 |
Curevac Netherlands B V |
Cancer vaccines for breast cancer
|
|
JP7585195B2
(ja)
|
2018-09-27 |
2024-11-18 |
ナイコード セラピューティクス アルメン アクスイェ セルスカプ |
ネオエピトープを選択する方法
|
|
WO2020072380A1
(en)
|
2018-10-01 |
2020-04-09 |
Cellular Research, Inc. |
Determining 5' transcript sequences
|
|
WO2020072700A1
(en)
|
2018-10-02 |
2020-04-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
|
CN109550044B
(zh)
*
|
2018-10-19 |
2022-05-03 |
杭州纽安津生物科技有限公司 |
通用性多肽疫苗及其在制备治疗/预防胰腺癌药物中的应用
|
|
CA3118947A1
(en)
*
|
2018-11-07 |
2020-05-14 |
Modernatx, Inc. |
Rna cancer vaccines
|
|
EP3877520B1
(en)
|
2018-11-08 |
2025-03-19 |
Becton, Dickson And Company |
Whole transcriptome analysis of single cells using random priming
|
|
JP7477888B2
(ja)
*
|
2018-11-15 |
2024-05-02 |
ノイスコム アーゲー |
個別化された癌ワクチンの作製のための癌変異の選択
|
|
EP4745247A2
(en)
|
2018-12-13 |
2026-05-20 |
Becton Dickinson Co |
SELECTIVE EXTENSION IN A SINGLE-CELL WHOLE-TRANSCRIPTOME ANALYSIS
|
|
US20220062394A1
(en)
|
2018-12-17 |
2022-03-03 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|
|
AU2019404547B2
(en)
*
|
2018-12-21 |
2025-01-30 |
Biontech Us Inc. |
Method and systems for prediction of HLA class II-specific epitopes and characterization of CD4+ T cells
|
|
GB201821207D0
(en)
|
2018-12-24 |
2019-02-06 |
Tcer Ab |
Immunotherapy therapy
|
|
GB201821205D0
(en)
*
|
2018-12-24 |
2019-02-06 |
Tcer Ab |
Immunotherapy
|
|
CA3126072A1
(en)
*
|
2019-01-08 |
2020-07-16 |
Caris Mpi, Inc. |
Genomic profiling similarity
|
|
EP3911678A1
(en)
*
|
2019-01-14 |
2021-11-24 |
Genentech, Inc. |
Methods of treating cancer with a pd-1 axis binding antagonist and an rna vaccine
|
|
WO2020150356A1
(en)
|
2019-01-16 |
2020-07-23 |
Becton, Dickinson And Company |
Polymerase chain reaction normalization through primer titration
|
|
CN113574178B
(zh)
|
2019-01-23 |
2024-10-29 |
贝克顿迪金森公司 |
与抗体关联的寡核苷酸
|
|
EP3921443A1
(en)
|
2019-02-08 |
2021-12-15 |
F. Hoffmann-La Roche AG |
Diagnostic and therapeutic methods for cancer
|
|
CN120099139A
(zh)
|
2019-02-14 |
2025-06-06 |
贝克顿迪金森公司 |
杂合体靶向和全转录物组扩增
|
|
WO2020167240A1
(en)
*
|
2019-02-15 |
2020-08-20 |
Rjan Holdng Ab |
Autologous cancer tumour associated extrachromosomal circular dna for use as a therapeutic vaccine
|
|
CN113784725A
(zh)
*
|
2019-03-01 |
2021-12-10 |
弗洛制药公司 |
个性化癌症疫苗的设计、制造和用途
|
|
CN113557298B
(zh)
|
2019-03-13 |
2024-08-27 |
东洋纺株式会社 |
核酸的生成和扩增
|
|
US11965208B2
(en)
|
2019-04-19 |
2024-04-23 |
Becton, Dickinson And Company |
Methods of associating phenotypical data and single cell sequencing data
|
|
CN112011833B
(zh)
*
|
2019-05-30 |
2024-04-26 |
上海桀蒙生物技术有限公司 |
筛选和分离肿瘤新生抗原的方法
|
|
MX2021014525A
(es)
|
2019-05-30 |
2022-03-17 |
Gritstone Bio Inc |
Adenovirus modificados.
|
|
CN120099137A
(zh)
|
2019-07-22 |
2025-06-06 |
贝克顿迪金森公司 |
单细胞染色质免疫沉淀测序测定
|
|
CN110277135B
(zh)
*
|
2019-08-10 |
2021-06-01 |
杭州新范式生物医药科技有限公司 |
一种基于预期疗效选择个体化肿瘤新抗原的方法和系统
|
|
WO2021055880A1
(en)
*
|
2019-09-20 |
2021-03-25 |
University Of Florida Researchfoundation, Incorporated |
Detection of antibodies against ran proteins from serum and tissue lysates
|
|
EP4031696A4
(en)
*
|
2019-09-20 |
2023-02-22 |
Navi Bio-Therapeutics, Inc. |
PERSONALIZED CANCER IMMUNOTHERAPY
|
|
US12394502B2
(en)
|
2019-10-02 |
2025-08-19 |
The General Hospital Corporation |
Method for predicting HLA-binding peptides using protein structural features
|
|
WO2021092066A1
(en)
|
2019-11-05 |
2021-05-14 |
Personalis, Inc. |
Estimating tumor purity from single samples
|
|
EP4055160B1
(en)
|
2019-11-08 |
2024-04-10 |
Becton Dickinson and Company |
Using random priming to obtain full-length v(d)j information for immune repertoire sequencing
|
|
CN112795647B
(zh)
*
|
2019-11-14 |
2022-08-16 |
北京肿瘤医院(北京大学肿瘤医院) |
一种肿瘤标志物及其应用
|
|
BR112022011357A2
(pt)
|
2019-12-13 |
2022-08-23 |
Genentech Inc |
Anticorpos isolado, um ou mais ácidos nucleicos isolados, um ou mais vetores, uma ou mais células hospedeiras, composição, kit, uso do anticorpo, métodos para produzir o anticorpo e método para tratar ou retardar a progressão de um câncer ly6g6d positivo
|
|
EP4090763B1
(en)
|
2020-01-13 |
2024-12-04 |
Becton Dickinson and Company |
Methods and compositions for quantitation of proteins and rna
|
|
WO2021146219A1
(en)
|
2020-01-13 |
2021-07-22 |
Becton, Dickinson And Company |
Cell capture using du-containing oligonucleotides
|
|
ES2993319T3
(en)
|
2020-01-29 |
2024-12-27 |
Becton Dickinson Co |
Barcoded wells for spatial mapping of single cells through sequencing
|
|
CN115151810A
(zh)
|
2020-02-25 |
2022-10-04 |
贝克顿迪金森公司 |
实现使用单细胞样品作为单色补偿对照的双特异性探针
|
|
US20230114434A1
(en)
|
2020-03-13 |
2023-04-13 |
Codiak Biosciences, Inc. |
Extracellular vesicles for treating neurological disorders
|
|
JP2023518414A
(ja)
|
2020-03-20 |
2023-05-01 |
コディアック バイオサイエンシーズ， インコーポレイテッド |
治療のための細胞外小胞
|
|
US11920202B2
(en)
|
2020-04-09 |
2024-03-05 |
University Of Connecticut |
Unbiased identification of tumor rejection mediating neoepitopes
|
|
US11661625B2
(en)
|
2020-05-14 |
2023-05-30 |
Becton, Dickinson And Company |
Primers for immune repertoire profiling
|
|
JP7854946B2
(ja)
|
2020-05-26 |
2026-05-07 |
ディオニス セラピューティクス インコーポレイテッド |
核酸人工ミニプロテオームライブラリー
|
|
CN115803445A
(zh)
|
2020-06-02 |
2023-03-14 |
贝克顿迪金森公司 |
用于5撇基因表达测定的寡核苷酸和珠
|
|
US11932901B2
(en)
|
2020-07-13 |
2024-03-19 |
Becton, Dickinson And Company |
Target enrichment using nucleic acid probes for scRNAseq
|
|
WO2022026909A1
(en)
|
2020-07-31 |
2022-02-03 |
Becton, Dickinson And Company |
Single cell assay for transposase-accessible chromatin
|
|
EP4192496A4
(en)
|
2020-08-06 |
2025-01-01 |
Gritstone bio, Inc. |
MULTIEPITOP VACCINE CASSETTES
|
|
EP4196612A1
(en)
|
2020-08-12 |
2023-06-21 |
Genentech, Inc. |
Diagnostic and therapeutic methods for cancer
|
|
CN116133682A
(zh)
*
|
2020-08-31 |
2023-05-16 |
环球生物科技再生医疗集团有限公司 |
个性化免疫原性组合物及其生产和使用方法
|
|
US20240082389A1
(en)
|
2020-09-23 |
2024-03-14 |
Lonza Sales Ag |
Methods of producing extracellular vesicles
|
|
US11058751B1
(en)
|
2020-11-20 |
2021-07-13 |
Think Therapeutics, Inc. |
Compositions for optimized RAS peptide vaccines
|
|
US11161892B1
(en)
|
2020-12-07 |
2021-11-02 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
US11739443B2
(en)
|
2020-11-20 |
2023-08-29 |
Becton, Dickinson And Company |
Profiling of highly expressed and lowly expressed proteins
|
|
US11421015B2
(en)
|
2020-12-07 |
2022-08-23 |
Think Therapeutics, Inc. |
Method of compact peptide vaccines using residue optimization
|
|
CN116710115A
(zh)
|
2020-11-20 |
2023-09-05 |
思维疗法股份有限公司 |
用于优化的肽疫苗的组合物和方法
|
|
CA3202176A1
(en)
|
2020-12-14 |
2022-06-23 |
Michael Steven ROONEY |
Tissue-specific antigens for cancer immunotherapy
|
|
US12392771B2
(en)
|
2020-12-15 |
2025-08-19 |
Becton, Dickinson And Company |
Single cell secretome analysis
|
|
US11464842B1
(en)
|
2021-04-28 |
2022-10-11 |
Think Therapeutics, Inc. |
Compositions and method for optimized peptide vaccines using residue optimization
|
|
EP4392140A1
(en)
|
2021-08-24 |
2024-07-03 |
BioNTech SE |
In vitro transcription technologies
|
|
EP4413580A4
(en)
|
2021-10-05 |
2025-08-13 |
Personalis Inc |
PERSONALIZED TESTS FOR PERSONALIZED CANCER MONITORING
|
|
EP4426829A1
(en)
|
2021-11-01 |
2024-09-11 |
Dana-Farber Cancer Institute, Inc. |
Biologically selected nucleic acid artificial mini-proteome libraries
|
|
CN118318038A
(zh)
|
2021-11-10 |
2024-07-09 |
东洋纺株式会社 |
改良的文库制备方法
|
|
CN114181287B
(zh)
*
|
2021-12-10 |
2023-09-19 |
商丘美兰生物工程有限公司 |
一种dna病毒疫苗的制备方法
|
|
CN114410778B
(zh)
*
|
2021-12-29 |
2024-03-19 |
中南大学湘雅医院 |
Pf543在制备pd-l1/pd-1单抗肿瘤免疫治疗药物中的应用
|
|
CN114350800B
(zh)
*
|
2021-12-29 |
2024-03-19 |
中南大学湘雅医院 |
Sphk1在制备pd-l1/pd-1单抗肿瘤免疫治疗药物中的应用
|
|
KR20230130804A
(ko)
*
|
2022-03-04 |
2023-09-12 |
(주)큐리진 |
순환종양세포 검출을 위한 아데노바이러스 5/3 형
|
|
EP4253550A1
(en)
|
2022-04-01 |
2023-10-04 |
GenCC GmbH 6 Co. KG |
Method for the manufacture of a viral system, a vector system or any transport system for cancer-specific crispr complexes
|
|
US20260021172A1
(en)
|
2022-04-28 |
2026-01-22 |
Carbocalyx Gmbh |
Personalized Anticancer Vaccine Comprising Glycoengineered Tumour Cells or Tumour Cell Fragments
|
|
WO2024015892A1
(en)
|
2022-07-13 |
2024-01-18 |
The Broad Institute, Inc. |
Hla-ii immunopeptidome methods and systems for antigen discovery
|
|
WO2024063788A1
(en)
*
|
2022-09-23 |
2024-03-28 |
BioNTech SE |
Compositions for delivery of malaria antigens and related methods
|
|
CN120225219A
(zh)
*
|
2022-09-23 |
2025-06-27 |
生物技术欧洲股份公司 |
用于递送肝期抗原的组合物及相关方法
|
|
WO2024083345A1
(en)
|
2022-10-21 |
2024-04-25 |
BioNTech SE |
Methods and uses associated with liquid compositions
|
|
WO2024157925A1
(ja)
|
2023-01-26 |
2024-08-02 |
東洋紡株式会社 |
リボソーマルｒｎａ由来の逆転写の抑制
|
|
WO2024231973A1
(ja)
*
|
2023-05-08 |
2024-11-14 |
株式会社日立製作所 |
情報処理装置
|
|
US12531162B1
(en)
*
|
2023-05-31 |
2026-01-20 |
Northeastern University |
Multi-dimensional phenotypic space for genotype to phenotype mapping and intelligent design of cancer drug therapies using a deep learning net
|
|
AU2024307171A1
(en)
|
2023-06-28 |
2026-01-15 |
Shanghai Regenelead Therapies Co., Ltd. |
Pharmaceutical composition containing cationic lipid and use thereof
|
|
WO2025024337A1
(en)
*
|
2023-07-24 |
2025-01-30 |
BioNTech SE |
Compositions for delivery of plasmodium antigens and related methods
|
|
WO2025064850A1
(en)
*
|
2023-09-22 |
2025-03-27 |
BioNTech SE |
Rna constructs with n-terminal degrons to enhance an immune response
|
|
WO2025097055A2
(en)
|
2023-11-02 |
2025-05-08 |
The Broad Institute, Inc. |
Compositions and methods of use of t cells in immunotherapy
|
|
US12562256B2
(en)
*
|
2023-11-07 |
2026-02-24 |
New York University |
Systems, methods and computer-accessible medium for identifying target pairs for CAR-T therapy
|
|
WO2025146078A1
(en)
*
|
2024-01-04 |
2025-07-10 |
Everest Medicines (China) Co., Ltd. |
Cancer vaccines and uses thereof
|
|
WO2025191449A1
(en)
|
2024-03-11 |
2025-09-18 |
Instadeep Ltd |
Systems and methods for machine learning-based genome annotation
|
|
WO2025202937A1
(en)
|
2024-03-26 |
2025-10-02 |
BioNTech SE |
Cancer vaccines
|
|
WO2025207807A1
(en)
*
|
2024-03-27 |
2025-10-02 |
The University Of Florida Research Foundation, Inc. |
Ctc rna-loaded nanoparticles and use thereof for the treatment of cancer
|
|
WO2025257735A1
(en)
|
2024-06-10 |
2025-12-18 |
BioNTech SE |
Systems and methods for machine learning model-based prediction of immune response
|
|
CN119049567B
(zh)
*
|
2024-08-08 |
2025-07-22 |
笙源生命科技(安吉)有限公司 |
一种基于单细胞测序区分嵌合体动物模型中异种杂交样本遗传物质和细胞物种来源的方法
|
|
EP4711456A1
(en)
|
2024-09-11 |
2026-03-18 |
GenCC GmbH & Co. KG |
Method for the manufacture of individualized crispr/cas complexes and individualized crispr/cas complexes
|
|
WO2026096894A1
(en)
|
2024-11-01 |
2026-05-07 |
BioNTech SE |
Methods and systems for mass-spectrometry-based detection of non-canonical peptides
|